CD4 and COVID-19: However, when the 17 COVID-19 survivors were divided into 9 non-severe patients and 8 severe patients, the median ratios of spike/control IFN-γ percentages of CD4+ and CD8+ T cell in the severe COVID-19 group were higher than those in the non-severe group (Figures E4A, B).